MetaADEDB 2.0 @ LMMD
Asenapine
(GMDCDXMAFMEDAG-CHHFXETESA-N)
Structure
SMILES
Clc1ccc2c(c1)[C@H]1CN(C[C@@H]1c1c(O2)cccc1)C.OC(=O)/C=C\C(=O)O
Molecular Formula:
C21H20ClNO5
Molecular Weight:
401.840
Log P:
3.9082
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
87.07
CAS Number(s):
85650-56-2
Synonym(s)
1.
Asenapine
2.
5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3-6,7)oxepino(4,5-c)pyrrole
3.
ORG 5222
4.
ORG-5222
5.
asenapine maleate
6.
saphris
External Link(s)
MeSHC522667
PubChem Compound6917875
ChEBI71248
KEGGdr:D02995
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DysgeusiaFAERS: 290
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Inappropriate schedule of drug administrationFAERS: 290US FAERS
3SomnolenceFAERS: 161US FAERS
4AkathisiaFAERS: 152
Canada Vigilance: 1
Canada Vigilance
US FAERS
5NauseaFAERS: 144
Canada Vigilance: 2
Canada Vigilance
US FAERS
6DizzinessFAERS: 138
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Incorrect route of drug administrationFAERS: 132US FAERS
8VomitingFAERS: 93US FAERS
9AgitationFAERS: 88
Canada Vigilance: 2
Canada Vigilance
US FAERS
10AnxietyFAERS: 86
Canada Vigilance: 4
Canada Vigilance
US FAERS
11Drug ineffectiveFAERS: 73
Canada Vigilance: 6
Canada Vigilance
US FAERS
12DystoniaFAERS: 73US FAERS
13Feeling abnormalFAERS: 62US FAERS
14HeadacheFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
15Restless Legs SyndromeFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
16TremorFAERS: 60US FAERS
17FatigueFAERS: 55US FAERS
18HypersensitivityFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
19RestlessnessFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Tardive DyskinesiaFAERS: 44US FAERS
21DysarthriaFAERS: 37US FAERS
22StomatitisFAERS: 36US FAERS
23Adverse eventFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Product taste abnormalFAERS: 34US FAERS
25Blood glucose increasedFAERS: 31US FAERS
26SyncopeFAERS: 31US FAERS
27Wrong technique in drug usage processFAERS: 31US FAERS
28No adverse eventFAERS: 29US FAERS
29OverdoseFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
30Product quality issueFAERS: 29US FAERS
31Musculoskeletal stiffnessFAERS: 28US FAERS
32Tongue blisteringFAERS: 27US FAERS
33AngioedemaFAERS: 25US FAERS
34HypotensionFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
35DroolingFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
36PruritusFAERS: 22US FAERS
37SomnambulismFAERS: 22US FAERS
38TachycardiaFAERS: 22US FAERS
39ArthralgiaFAERS: 21US FAERS
40Completed SuicideFAERS: 21US FAERS
41Drug dose omissionFAERS: 21US FAERS
42AngerFAERS: 20US FAERS
43Chest PainFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Joint swellingFAERS: 20US FAERS
45MalaiseFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
46UrticariaFAERS: 20US FAERS
47Oral painFAERS: 19US FAERS
48SwellingFAERS: 19US FAERS
49AgeusiaFAERS: 18US FAERS
50Memory impairmentFAERS: 18US FAERS
51Drug administered to patient of inappropriate ageFAERS: 17US FAERS
52EnuresisFAERS: 17US FAERS
53MyalgiaFAERS: 17US FAERS
54PainFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Weight decreasedFAERS: 17US FAERS
56AstheniaFAERS: 16US FAERS
57Myocardial InfarctionFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
58Oropharyngeal blisteringFAERS: 16US FAERS
59PalpitationsFAERS: 16US FAERS
60AlopeciaFAERS: 15US FAERS
61ConstipationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
62HypersomniaFAERS: 15US FAERS
63DisorientationFAERS: 14US FAERS
64Suicide attemptFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
65Abdominal discomfortFAERS: 13US FAERS
66Intentional product misuseFAERS: 13US FAERS
67Muscle tightnessFAERS: 13US FAERS
68SchizophreniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Unevaluable eventFAERS: 13US FAERS
70Blood prolactin increasedFAERS: 12US FAERS
71Cerebrovascular accidentFAERS: 12US FAERS
72ErythemaFAERS: 12US FAERS
73Lip swellingFAERS: 12US FAERS
74NervousnessFAERS: 12US FAERS
75Therapeutic product ineffectiveFAERS: 12US FAERS
76AmnesiaFAERS: 11US FAERS
77Neuroleptic Malignant SyndromeFAERS: 11US FAERS
78ParanoiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
79AbasiaFAERS: 10US FAERS
80Abdominal PainFAERS: 10US FAERS
81AcneFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Chest discomfortFAERS: 10US FAERS
83CryingFAERS: 10US FAERS
84LacerationFAERS: 10US FAERS
85Dental cariesFAERS: 9US FAERS
86Drug prescribing errorFAERS: 9US FAERS
87DysphemiaFAERS: 9US FAERS
88Emotional disorderFAERS: 9US FAERS
89Feeling ColdFAERS: 9US FAERS
90Feeling jitteryFAERS: 9US FAERS
91GlossitisFAERS: 9US FAERS
92HungerFAERS: 9US FAERS
93Incorrect dose administeredFAERS: 9US FAERS
94LethargyFAERS: 9US FAERS
95RetchingFAERS: 9US FAERS
96ThirstFAERS: 9US FAERS
97Throat irritationFAERS: 9US FAERS
98Unresponsive to stimuliFAERS: 9US FAERS
99White blood cell count decreasedFAERS: 9US FAERS
100Anaphylactic shockFAERS: 8US FAERS
101Aphthous StomatitisFAERS: 8US FAERS
102Application site reactionFAERS: 8US FAERS
103BradyphreniaFAERS: 8US FAERS
104Drug DependenceFAERS: 8US FAERS
105nervous system disorderFAERS: 8US FAERS
106Back PainFAERS: 7US FAERS
107HypomaniaFAERS: 7US FAERS
108Joint stiffnessFAERS: 7US FAERS
109Medication ErrorFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
110Muscle RigidityFAERS: 7US FAERS
111Poor quality sleepFAERS: 7US FAERS
112Therapeutic response unexpectedFAERS: 7US FAERS
113ToothacheFAERS: 7US FAERS
114Urinary RetentionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
115BruxismFAERS: 6US FAERS
116ChillsFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
117DiscomfortFAERS: 6US FAERS
118Drug screen positiveFAERS: 6US FAERS
119Embolic strokeFAERS: 6US FAERS
120FormicationFAERS: 6US FAERS
121Mood swingsFAERS: 6US FAERS
122Oropharyngeal painFAERS: 6US FAERS
123TorticollisFAERS: 6US FAERS
124WheezingFAERS: 6US FAERS
125Acute myocardial infarctionFAERS: 5US FAERS
126AsphyxiaFAERS: 5US FAERS
127BradycardiaFAERS: 5US FAERS
128ChokingFAERS: 5US FAERS
129Drug administration errorFAERS: 5US FAERS
130DyspepsiaFAERS: 5US FAERS
131EpistaxisFAERS: 5US FAERS
132Euphoric moodFAERS: 5US FAERS
133Feeling of body temperature changeFAERS: 5US FAERS
134Intentional self-injuryFAERS: 5US FAERS
135Mucosal excoriationFAERS: 5US FAERS
136Musculoskeletal PainFAERS: 5US FAERS
137Obsessive-Compulsive DisorderFAERS: 5US FAERS
138Oral mucosal exfoliationFAERS: 5US FAERS
139Oromandibular dystoniaFAERS: 5US FAERS
140Product blister packaging issueFAERS: 5US FAERS
141Product packaging issueFAERS: 5US FAERS
142Rash erythematousFAERS: 5US FAERS
143StressFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Tongue exfoliationFAERS: 5US FAERS
145TrismusFAERS: 5US FAERS
146AphasiaFAERS: 4US FAERS
147Blood potassium decreasedFAERS: 4US FAERS
148Cardiac ArrestFAERS: 4US FAERS
149DehydrationFAERS: 4US FAERS
150Depressed moodFAERS: 4US FAERS
151Disease recurrenceFAERS: 4US FAERS
152Drug ineffective for unapproved indicationFAERS: 4US FAERS
153Food cravingFAERS: 4US FAERS
154Impaired work abilityFAERS: 4US FAERS
155LaryngospasmFAERS: 4US FAERS
156MydriasisFAERS: 4US FAERS
157Oral candidiasisFAERS: 4US FAERS
158Peripheral swellingFAERS: 4US FAERS
159Personality ChangeFAERS: 4US FAERS
160Physical assaultFAERS: 4US FAERS
161PneumoniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Pulmonary EmbolismFAERS: 4US FAERS
163Sexual DysfunctionFAERS: 4US FAERS
164Sudden onset of sleepFAERS: 4US FAERS
165Temperature intoleranceFAERS: 4US FAERS
166Urinary IncontinenceFAERS: 4US FAERS
167VIIth nerve paralysisFAERS: 4US FAERS
168VertigoFAERS: 4US FAERS
169Accidental exposureFAERS: 3US FAERS
170Activation syndromeFAERS: 3US FAERS
171Activities of daily living impairedFAERS: 3US FAERS
172Acute psychosisFAERS: 3US FAERS
173Angina PectorisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Application site vesiclesFAERS: 3US FAERS
175AsthmaFAERS: 3US FAERS
176AtaxiaFAERS: 3US FAERS
177Bipolar I disorderFAERS: 3US FAERS
178Blood cholesterol increasedFAERS: 3US FAERS
179Blood creatine phosphokinase increasedFAERS: 3US FAERS
180Blood sodium decreasedFAERS: 3US FAERS
181Blood triglycerides increasedFAERS: 3US FAERS
182Burning sensationFAERS: 3US FAERS
183ConjunctivitisFAERS: 3US FAERS
184Deep Vein ThrombosisFAERS: 3US FAERS
185DeliriumFAERS: 3US FAERS
186Depressed Level of ConsciousnessFAERS: 3US FAERS
187Diabetic KetoacidosisFAERS: 3US FAERS
188DiplopiaFAERS: 3US FAERS
189DissociationFAERS: 3US FAERS
190Erectile dysfunctionFAERS: 3US FAERS
191Expired drug administeredFAERS: 3US FAERS
192FlushingFAERS: 3US FAERS
193Head discomfortFAERS: 3US FAERS
194HyperphagiaFAERS: 3US FAERS
195Hypoaesthesia facialFAERS: 3US FAERS
196HypoventilationFAERS: 3US FAERS
197ImmobileFAERS: 3US FAERS
198Inappropriate schedule of product administrationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
199IncoherentFAERS: 3US FAERS
200InfluenzaFAERS: 3US FAERS
201Lobar PneumoniaFAERS: 3US FAERS
202NasopharyngitisFAERS: 3US FAERS
203NephrolithiasisFAERS: 3US FAERS
204NeutropeniaFAERS: 3US FAERS
205Neutrophil count decreasedFAERS: 3US FAERS
206Nonspecific reactionFAERS: 3US FAERS
207Oculogyric crisisFAERS: 3US FAERS
208Orthostatic hypertensionFAERS: 3US FAERS
209Panic DisorderFAERS: 3US FAERS
210Prescribed underdoseFAERS: 3US FAERS
211PresyncopeFAERS: 3US FAERS
212Product barcode issueFAERS: 3US FAERS
213Product solubility abnormalFAERS: 3US FAERS
214Product storage errorFAERS: 3US FAERS
215Product use issueFAERS: 3US FAERS
216Respiratory arrestFAERS: 3US FAERS
217RhabdomyolysisFAERS: 3US FAERS
218ScabFAERS: 3US FAERS
219ScreamingFAERS: 3US FAERS
220Serotonin SyndromeFAERS: 3US FAERS
221SneezingFAERS: 3US FAERS
222StuporFAERS: 3US FAERS
223TinnitusFAERS: 3US FAERS
224Tongue discomfortFAERS: 3US FAERS
225Tongue eruptionFAERS: 3US FAERS
226Visual ImpairmentFAERS: 3US FAERS
227Wrong technique in product usage processFAERS: 3US FAERS
228Abdominal adhesionsFAERS: 2US FAERS
229AkinesiaFAERS: 2US FAERS
230Alcohol abuseFAERS: 2US FAERS
231Ammonia increasedFAERS: 2US FAERS
232Application site ulcerFAERS: 2US FAERS
233ArthritisFAERS: 2US FAERS
234Bifascicular blockFAERS: 2US FAERS
235Bipolar DisorderFAERS: 2US FAERS
236Blood glucose abnormalFAERS: 2US FAERS
237Blood testosterone decreasedFAERS: 2US FAERS
238Breast tendernessFAERS: 2US FAERS
239CatatoniaFAERS: 2US FAERS
240Choking sensationFAERS: 2US FAERS
241Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
242Compulsive shoppingFAERS: 2US FAERS
243DeafnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
244Diabetes MellitusFAERS: 2US FAERS
245Drug dispensing errorFAERS: 2US FAERS
246Drug screen false positiveFAERS: 2US FAERS
247Drug screen negativeFAERS: 2US FAERS
248Drug withdrawal syndromeFAERS: 2US FAERS
249DysuriaFAERS: 2US FAERS
250Flat affectFAERS: 2US FAERS
251FlatulenceFAERS: 2US FAERS
252Foaming at mouthFAERS: 2US FAERS
253Hallucinations, mixedFAERS: 2US FAERS
254Head titubationFAERS: 2US FAERS
255HomicideFAERS: 2US FAERS
256Hyporesponsive to stimuliFAERS: 2US FAERS
257Impaired driving abilityFAERS: 2US FAERS
258Incorrect route of product administrationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
259Increased tendency to bruiseFAERS: 2US FAERS
260Infectious MononucleosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
261InflammationFAERS: 2US FAERS
262Initial insomniaFAERS: 2US FAERS
263Left Ventricular HypertrophyFAERS: 2US FAERS
264Limb discomfortFAERS: 2US FAERS
265LymphadenopathyFAERS: 2US FAERS
266Mental impairmentFAERS: 2US FAERS
267Middle insomniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
268Migraine with AuraFAERS: 2US FAERS
269Muscle FatigueFAERS: 2US FAERS
270Ocular discomfortFAERS: 2US FAERS
271Oral administration complicationFAERS: 2US FAERS
272Oral mucosal eruptionFAERS: 2US FAERS
273Oral mucosal erythemaFAERS: 2US FAERS
274PancytopeniaFAERS: 2US FAERS
275PoisoningFAERS: 2US FAERS
276PolyuriaFAERS: 2US FAERS
277Prescribed overdoseFAERS: 2US FAERS
278Psychiatric decompensationFAERS: 2US FAERS
279ShopliftingFAERS: 2US FAERS
280Skin lesionFAERS: 2US FAERS
281StaringFAERS: 2US FAERS
282Stevens-Johnson SyndromeFAERS: 2US FAERS
283TachyphreniaFAERS: 2US FAERS
284Transcription medication errorFAERS: 2US FAERS
285UlcerFAERS: 2US FAERS
286Wrong drug administeredFAERS: 2US FAERS
287AcarodermatitisFAERS: 1US FAERS
288Accidental exposure to productFAERS: 1US FAERS
289AgranulocytosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
290Alanine Aminotransferase IncreasedFAERS: 1US FAERS
291Amphetamines positiveFAERS: 1US FAERS
292Anaphylactoid ReactionFAERS: 1US FAERS
293AneurysmFAERS: 1US FAERS
294AnosmiaFAERS: 1US FAERS
295AphagiaFAERS: 1US FAERS
296AphoniaFAERS: 1US FAERS
297Apparent deathFAERS: 1US FAERS
298Apparent life threatening eventFAERS: 1US FAERS
299Application site inflammationFAERS: 1US FAERS
300Application site irritationFAERS: 1US FAERS
301Application site lacerationFAERS: 1US FAERS
302Application site painFAERS: 1US FAERS
303ArthropathyFAERS: 1US FAERS
304AversionFAERS: 1US FAERS
305BedriddenFAERS: 1US FAERS
306Benzodiazepine drug levelFAERS: 1US FAERS
307Bladder painFAERS: 1US FAERS
308BlindnessFAERS: 1US FAERS
309Blood amylase increasedFAERS: 1US FAERS
310Blood blisterFAERS: 1US FAERS
311Blood count abnormalFAERS: 1US FAERS
312Blood electrolytes abnormalFAERS: 1US FAERS
313Blood potassium increasedFAERS: 1US FAERS
314Bone density decreasedFAERS: 1US FAERS
315Breath alcohol test positiveFAERS: 1US FAERS
316BronchitisFAERS: 1US FAERS
317BronchospasmFAERS: 1US FAERS
318Burning Mouth SyndromeFAERS: 1US FAERS
319CandidiasisFAERS: 1US FAERS
320Cardiac FlutterFAERS: 1US FAERS
321Carotid artery occlusionFAERS: 1US FAERS
322CheilitisFAERS: 1US FAERS
323Chemical burn of gastrointestinal tractFAERS: 1US FAERS
324Chemical injuryFAERS: 1US FAERS
325ChoreaFAERS: 1US FAERS
326ChromaturiaFAERS: 1US FAERS
327ClumsinessFAERS: 1US FAERS
328Cold sweatFAERS: 1US FAERS
329Coma scale abnormalFAERS: 1US FAERS
330Complex partial seizuresFAERS: 1US FAERS
331Conversion disorderFAERS: 1US FAERS
332CyanosisFAERS: 1US FAERS
333Device breakageFAERS: 1US FAERS
334Disseminated Intravascular CoagulationFAERS: 1US FAERS
335Dissociative disorderFAERS: 1US FAERS
336Disturbance in sexual arousalFAERS: 1US FAERS
337Dreamy stateFAERS: 1US FAERS
338Drug administered at inappropriate siteFAERS: 1US FAERS
339Drug diversionFAERS: 1US FAERS
340Drug effect incompleteFAERS: 1US FAERS
341Drug withdrawal headacheFAERS: 1US FAERS
342DysgraphiaFAERS: 1US FAERS
343DysphoniaFAERS: 1US FAERS
344Early satietyFAERS: 1US FAERS
345EcchymosisFAERS: 1US FAERS
346EczemaFAERS: 1US FAERS
347Electrocardiogram QT interval abnormalFAERS: 1US FAERS
348Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
349Elevated moodFAERS: 1US FAERS
350EpilepsyFAERS: 1US FAERS
351EructationFAERS: 1US FAERS
352Essential TremorFAERS: 1US FAERS
353Ex-tobacco userFAERS: 1US FAERS
354Excessive masturbationFAERS: 1US FAERS
355Expired product administeredFAERS: 1US FAERS
356Eye painFAERS: 1US FAERS
357Feelings of worthlessnessFAERS: 1US FAERS
358Food AllergyFAERS: 1US FAERS
359GalactostasisFAERS: 1US FAERS
360GamblingFAERS: 1US FAERS
361GastritisFAERS: 1US FAERS
362Gastrointestinal motility disorderFAERS: 1US FAERS
363GingivitisFAERS: 1US FAERS
364HemiparesisFAERS: 1US FAERS
365HemiplegiaFAERS: 1US FAERS
366HepatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Heteronymous diplopiaFAERS: 1US FAERS
368Hip surgeryFAERS: 1US FAERS
369HostilityFAERS: 1US FAERS
370HypohidrosisFAERS: 1US FAERS
371HypokinesiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
372HypoxiaFAERS: 1US FAERS
373Impaired gastric emptyingFAERS: 1US FAERS
374Inappropriate affectFAERS: 1US FAERS
375IncontinenceFAERS: 1US FAERS
376Incorrect drug dosage form administeredFAERS: 1US FAERS
377Intentional dose omissionFAERS: 1US FAERS
378Intentional drug misuseFAERS: 1US FAERS
379Intercepted drug prescribing errorFAERS: 1US FAERS
380Intestinal gangreneFAERS: 1US FAERS
381Irritable Bowel SyndromeFAERS: 1US FAERS
382LeukopeniaFAERS: 1US FAERS
383Lipase increasedFAERS: 1US FAERS
384Lipoma of breastFAERS: 1US FAERS
385Loss of dreamingFAERS: 1US FAERS
386Loss of personal independence in daily activitiesFAERS: 1US FAERS
387Lower respiratory tract infectionFAERS: 1US FAERS
388Maternal exposure during pregnancyFAERS: 1US FAERS
389MenorrhagiaFAERS: 1US FAERS
390Mental status changesFAERS: 1US FAERS
391Monocyte count increasedFAERS: 1US FAERS
392Mononucleosis syndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
393Motion SicknessFAERS: 1US FAERS
394Multiple SclerosisFAERS: 1US FAERS
395MyoclonusFAERS: 1US FAERS
396Neck PainFAERS: 1US FAERS
397Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
398Nerve injuryFAERS: 1US FAERS
399NeuralgiaFAERS: 1US FAERS
400No reaction on previous exposure to drugFAERS: 1US FAERS
401Non-cardiac chest painFAERS: 1US FAERS
402Nuchal RigidityFAERS: 1US FAERS
403NystagmusFAERS: 1US FAERS
404ObesityFAERS: 1US FAERS
405Obsessive thoughtsFAERS: 1US FAERS
406OligodipsiaFAERS: 1US FAERS
407Oral pruritusFAERS: 1US FAERS
408Oropharyngeal discomfortFAERS: 1US FAERS
409OsteopeniaFAERS: 1US FAERS
410Pericardial effusionFAERS: 1US FAERS
411PetechiaeFAERS: 1US FAERS
412Physical abuseFAERS: 1US FAERS
413Post-Traumatic Stress DisorderFAERS: 1US FAERS
414Precancerous cells presentFAERS: 1US FAERS
415PregnancyFAERS: 1US FAERS
416Product outer packaging issueFAERS: 1US FAERS
417Product package associated injuryFAERS: 1US FAERS
418Product packaging confusionFAERS: 1US FAERS
419Product packaging quantity issueFAERS: 1US FAERS
420Product physical issueFAERS: 1US FAERS
421Product use complaintFAERS: 1US FAERS
422Psychiatric symptomFAERS: 1US FAERS
423Psychomotor skills impairedFAERS: 1US FAERS
424Pulmonary HypertensionFAERS: 1US FAERS
425Reaction to drug excipientsFAERS: 1US FAERS
426Respiratory FailureFAERS: 1US FAERS
427Respiratory distressFAERS: 1US FAERS
428Respiratory tract congestionFAERS: 1US FAERS
429Rotator cuff syndromeFAERS: 1US FAERS
430Salivary gland painFAERS: 1US FAERS
431Sclerosing encapsulating peritonitisFAERS: 1US FAERS
432Sensory levelFAERS: 1US FAERS
433Sjogren's SyndromeFAERS: 1US FAERS
434Skin lacerationFAERS: 1US FAERS
435Skin reactionFAERS: 1US FAERS
436Sleep ParalysisFAERS: 1US FAERS
437Sleep-related eating disorderFAERS: 1US FAERS
438SluggishnessFAERS: 1US FAERS
439SoliloquyFAERS: 1US FAERS
440StrabismusFAERS: 1US FAERS
441Sudden deathFAERS: 1US FAERS
442Supraventricular tachycardiaFAERS: 1US FAERS
443Suspected counterfeit productFAERS: 1US FAERS
444Tablet physical issueFAERS: 1US FAERS
445TensionFAERS: 1US FAERS
446Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
447ThrombocytopeniaFAERS: 1US FAERS
448ThrombosisFAERS: 1US FAERS
449Tongue bitingFAERS: 1US FAERS
450Tongue dysplasiaFAERS: 1US FAERS
451Tongue movement disturbanceFAERS: 1US FAERS
452Toxicity to various agentsFAERS: 1US FAERS
453TuberculosisFAERS: 1US FAERS
454Urinary hesitationFAERS: 1US FAERS
455Urinary tract infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Urine output increasedFAERS: 1US FAERS
457Vaginal DischargeFAERS: 1US FAERS
458Ventricular FibrillationFAERS: 1US FAERS
459Victim of homicideFAERS: 1US FAERS
460VulvitisFAERS: 1US FAERS
461Waist circumference increasedFAERS: 1US FAERS
462furuncleFAERS: 1US FAERS
463muscle injuryFAERS: 1US FAERS
464Blunted affectCanada Vigilance: 1Canada Vigilance
465Emotional povertyCanada Vigilance: 1Canada Vigilance
466Obsessive-compulsive symptomCanada Vigilance: 1Canada Vigilance
467Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.